Venture
from24/7 Wall St.
2 months agoNancy Pelosi's Latest AI Stock Pick Tempus AI Is Up Big Today
Tempus AI's acquisition of Ambry Genetics signals a strategic push in the AI healthcare sector.
Recent insider selling by CFO raises concerns, but analysts view it as a potential buying opportunity.